Helminth-Tuberculosis Co-infection: An Immunologic Perspective

Trends in Immunology

Volumn 37, Issue 9, 2016, Pages 597-607

  Babu, Subash ^a,b   Nutman, Thomas B ^b  

^a NATIONAL INSTITUTE OF FASHION TECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL MODEL; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; MIXED INFECTION; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; TUBERCULOSIS; ANIMAL; ANIMAL MODEL; HELMINTH; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOMODULATION; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; COINFECTION; HELMINTHIASIS; HELMINTHS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOMODULATION; MODELS, ANIMAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84992497952     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.07.005     Document Type: Review

References (88)

1. 1 Hotez, P.J., et al. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118 (2008), 1311–1321.
2. 2 Allen, J.E., Maizels, R.M., Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 11 (2011), 375–388.
3. 3 Nutman, T.B., Lymphatic filariasis: new insights and prospects for control. Curr. Opin. Infect. Dis. 14 (2001), 539–546.
4. 4 Dheda, K., et al. Tuberculosis. Lancet 387 (2016), 1211–1226.
5. 5 WHO, Global Tuberculosis Report. 2013, WHO.
6. 6 O'Garra, A., et al. The immune response in tuberculosis. Annu. Rev. Immunol. 31 (2013), 475–527.
7. 7 Getahun, H., et al. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 373 (2015), 1179–1180.
8. 8 Salgame, P., et al. Latent tuberculosis infection -–revisiting and revising concepts. Tuberculosis (Edinb.) 95 (2015), 373–384.
9. 9 Grencis, R.K., Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes. Annu. Rev. Immunol. 33 (2015), 201–225.
10. 10 Babu, S., Nutman, T.B., Immunology of lymphatic filariasis. Parasite Immunol. 36 (2014), 338–346.
11. 11 McKenzie, A.N., et al. Innate lymphoid cells in inflammation and immunity. Immunity 41 (2014), 366–374.
12. 12 McSorley, H.J., et al. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int. J. Parasitol. 43 (2013), 301–310.
13. 13 Metenou, S., Nutman, T.B., Regulatory T cell subsets in filarial infection and their function. Front. Immunol., 4, 2013, 305.
14. 14 Semnani, R.T., et al. Filaria-induced immune evasion: suppression by the infective stage of Brugia malayi at the earliest host–parasite interface. J. Immunol. 172 (2004), 6229–6238.
15. 15 Semnani, R.T., Nutman, T.B., Toward an understanding of the interaction between filarial parasites and host antigen-presenting cells. Immunol. Rev. 201 (2004), 127–138.
16. 16 King, C.L., et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J. Clin. Invest. 92 (1993), 1667–1673.
17. 17 Gaze, S., et al. Immunology of experimental and natural human hookworm infection. Parasite Immunol. 36 (2014), 358–366.
18. 18 Maizels, R.M., Yazdanbakhsh, M., Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol., 3, 2003 733-444.
19. 19 Mishra, P.K., et al. Systemic impact of intestinal helminth infections. Mucosal Immunol. 7 (2014), 753–762.
20. 20 Allen, J.E., Wynn, T.A., Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog., 7, 2011, e1002003.
21. 21 Babu, S., Nutman, T.B., Immunopathogenesis of lymphatic filarial disease. Semin. Immunopathol. 34 (2013), 847–861.
22. 22 Strachan, D.P., Lifestyle and atopy. Lancet 353 (1999), 1457–1458.
23. 23 Yazdanbakhsh, M., et al. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002), 490–494.
24. 24 Cooper, P.J., Interactions between helminth parasites and allergy. Curr. Opin. Allergy Clin. Immunol. 9 (2009), 29–37.
25. 25 Wilson, M.S., Maizels, R.M., Regulation of allergy and autoimmunity in helminth infection. Clin. Rev. Allergy Immunol. 26 (2004), 35–50.
26. 26 Weinstock, J.V., Elliott, D.E., Helminth infections decrease host susceptibility to immune-mediated diseases. J. Immunol. 193 (2014), 3239–3247.
27. 27 Levine, M.M., Kaper, J.B., Live oral vaccines against cholera: an update. Vaccine 11 (1993), 207–212.
28. 28 Baily, G.V., Tuberculosis prevention Trial. Madras. Indian J. Med. Res. 72:Suppl (1980), 1–74.
29. 29 Patriarca, P.A., et al. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 13 (1991), 926–939.
30. 30 Suharyono, et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340 (1992), 689–694.
31. 31 Cooper, P.J., et al. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J. Infect. Dis. 178 (1998), 1133–1138.
32. 32 Prost, A., et al. Response to tetanus immunization in onchocerciasis patients. Ann. Trop. Med. Parasitol. 77 (1983), 83–85.
33. 33 Nookala, S., et al. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect. Immun. 72 (2004), 2598–2604.
34. 34 Elliott, A.M., et al. Effects of maternal and infant coinfections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 29 (2010), 247–255.
35. 35 Barry, C.E. 3rd, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7 (2009), 845–855.
36. 36 Cooper, A.M., Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27 (2009), 393–422.
37. 37 Khader, S.A., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007), 369–377.
38. 38 Cooper, A.M., Khader, S.A., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226 (2008), 191–204.
39. 39 Darrah, P.A., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13 (2007), 843–850.
40. 40 Jasenosky, L.D., et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol. Rev. 264 (2015), 74–87.
41. 41 Mayer-Barber, K.D., Sher, A., Cytokine and lipid mediator networks in tuberculosis. Immunol. Rev. 264 (2015), 264–275.
42. 42 Ottenhoff, T.H., New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol. 20 (2012), 419–428.
43. 43 Metenou, S., et al. Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr. Opin. HIV AIDS 7 (2012), 231–238.
44. 44 Rougemont, A., et al. Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet, 1, 1977, 309.
45. 45 Buck, A.A., et al. Onchocerciasis: some new epidemiologic and clinical findings. Results of an epidemiologic study in the Republic of Chad. Am. J. Trop. Med. Hyg. 18 (1969), 217–230.
46. 46 Stewart, G.R., et al. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin. Exp. Immunol. 117 (1999), 517–523.
47. 47 Gebreegziabiher, D., et al. Helminth infection increases the probability of indeterminate QuantiFERON gold in tube results in pregnant women. Biomed. Res. Int., 2014, 2014, 364137.
48. 48 Thomas, T.A., et al. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics 126 (2010), e1522–e1529.
49. 49 van Soelen, N., et al. Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: a cross-sectional community-based study. BMC Infect. Dis., 12, 2012, 211.
50. 50 Lipner, E.M., et al. Coincident filarial, intestinal helminth, and mycobacterial infection: helminths fail to influence tuberculin reactivity, but BCG influences hookworm prevalence. Am. J. Trop. Med. Hyg. 74 (2006), 841–847.
51. 51 Neto, L.M., et al. Enteroparasitosis prevalence and parasitism influence in clinical outcomes of tuberculosis patients with or without HIV coinfection in a reference hospital in Rio de Janeiro (2000-2006). Braz. J. Infect. Dis. 13 (2009), 427–432.
52. 52 Zevallos, K., et al. Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and coinfections. Am. J. Trop. Med. Hyg. 83 (2010), 319–325.
53. 53 Van der Zalm, M.M., et al. The effect of deworming on tests of tuberculosis infection in children with recent tuberculosis exposure–a randomized controlled trial. Pediatr. Infect. Dis. J. 35 (2016), 706–708.
54. 54 Tristao-Sa, R., et al. Intestinal nematodes and pulmonary tuberculosis. Rev. Soc. Bras. Med. Trop. 35 (2002), 533–535.
55. 55 Elias, D., et al. Are intestinal helminths risk factors for developing active tuberculosis?. Trop. Med. Int. Health 11 (2006), 551–558.
56. 56 Brown, M., et al. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am. J. Trop. Med. Hyg. 74 (2006), 819–825.
57. 57 Elliott, A.M., et al. Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans. Trans. R. Soc. Trop. Med. Hyg. 97 (2003), 477–480.
58. 58 Resende Co, T., et al. Intestinal helminth coinfection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin. Exp. Immunol. 147 (2007), 45–52.
59. 59 Abate, E., et al. Asymptomatic helminth infection in active tuberculosis is associated with increased regulatory and Th-2 responses and a lower sputum smear positivity. PLoS Negl. Trop. Dis., 9, 2015, e0003994.
60. 60 Abate, E., et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial. Int. J. Parasitol. 45 (2015), 133–140.
61. 61 Chatterjee, S., et al. Incidence of active pulmonary tuberculosis in patients with coincident filarial and/or intestinal helminth infections followed longitudinally in South India. PLoS ONE, 9, 2014, e94603.
62. 62 Roy, A., et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. Br. Med. J., 349, 2014, g4643.
63. 63 Elias, D., et al. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin. Exp. Immunol. 123 (2001), 219–225.
64. 64 Malhotra, I., et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J. Immunol. 162 (1999), 6843–6848.
65. 65 Elias, D., et al. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26 (2008), 3897–3902.
66. 66 Talaat, K.R., et al. Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosis. J. Infect. Dis. 193 (2006), 196–204.
67. 67 Babu, S., et al. Human type 1 and 17 Responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J. Infect. Dis. 200 (2009), 288–298.
68. 68 Soboslay, P.T., et al. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin. Exp. Immunol. 89 (1992), 407–413.
69. 69 Steel, C., et al. Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J. Infect. Dis. 164 (1991), 581–587.
70. 70 Babu, S., et al. Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy. PLoS Negl. Trop. Dis., 3, 2009, e489.
71. 71 Chatterjee, S., et al. Filarial infection modulates the immune response to Mycobacterium tuberculosis through expansion of CD4+ IL-4 memory T cells. J. Immunol. 194 (2015), 2706–2714.
72. 72 George, P.J., et al. Modulation of mycobacterial-specific Th1 and Th17 cells in latent tuberculosis by coincident hookworm infection. J. Immunol. 190 (2013), 5161–5168.
73. 73 George, P.J., et al. Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection. Tuberculosis (Edinb) 95 (2015), 822–828.
74. 74 Toulza, F., et al. Mycobacterium tuberculosis-specific CD4(+) T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. Eur. J. Immunol. 46 (2016), 752–761.
75. 75 George, P.J., et al. Helminth infections coincident with active pulmonary tuberculosis inhibit mono- and multifunctional CD4+ and CD8+ T cell responses in a process dependent on IL-10. PLoS Pathog., 10, 2014, e1004375.
76. 76 Pearlman, E., et al. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J. Immunol. 151 (1993), 4857–4864.
77. 77 Sacco, R., et al. Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin. Immunol. 104 (2002), 274–281.
78. 78 Frantz, F.G., et al. Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis. PLoS Negl. Trop. Dis., 4, 2010, e700.
79. 79 Elias, D., et al. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin. Exp. Immunol. 139 (2005), 398–404.
80. 80 Potian, J.A., et al. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J. Exp. Med. 208 (2011), 1863–1874.
81. 81 Dias, A.T., et al. Lower production of IL-17A and increased susceptibility to Mycobacterium bovis in mice coinfected with Strongyloides venezuelensis. Mem. Inst. Oswaldo Cruz 106 (2011), 617–619.
82. 82 Obieglo, K., et al. Chronic gastrointestinal nematode infection mutes immune responses to mycobacterial infection distal to the gut. J. Immunol. 196 (2016), 2262–2271.
83. 83 Frantz, F.G., et al. The immune response to toxocariasis does not modify susceptibility to Mycobacterium tuberculosis infection in BALB/c mice. Am. J. Trop. Med. Hyg. 77 (2007), 691–698.
84. 84 Rafi, W., et al. Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection. Infect. Immun. 83 (2015), 1217–1223.
85. 85 Hubner, M.P., et al. Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection. PLoS Negl. Trop. Dis., 6, 2012, e1970.
86. 86 Monin, L., et al. Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. J. Clin. Invest. 125 (2015), 4699–4713.
87. 87 Hotez, P.J., et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl. Trop. Dis., 8, 2014, e2865.
88. 88 Edelman, R., Perspective on the development and deployment of rotavirus vaccines. Pediatr. Infect. Dis. J. 6 (1987), 704–710.